Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-41.61	48.23	82.59
Graham Fair Price	51.38	9.97	6.59
PEG	-69.03	0.16	-0.52
Price/Book	14.28	2.08	1.82
Price/Cash Flow	616.97	308.38	43.01
Prices/Earnings	-47.32	19.19	36.43
Price/Sales	-17.90	9.63	11.73
Price/FCF	616.97	308.38	43.01
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.93	0.31	0.32
Operating Margin	63.63	0.14	0.09
ROA	110.91	0.02	< 0.005
ROE	0.01	0.03	116.92
ROIC	< 0.005	0.02	148.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.32	-0.36	-11.72
Dividends QOQ	10.22	-0.92	-90.97
EBIT QOQ	-0.72	1.34	87.23
EPS QOQ	-0.70	1.19	70.10
FCF QOQ	0.97	-0.84	-13.62
Revenue QOQ	-0.32	0.43	36.54
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	147.16	107.94	-26.65
Days Sales Outstanding (DSO)	100.40	79.43	-20.88
Inventory Turnover	0.61	0.83	36.33
Debt/Capitalization	0.12	0.17	37.82
Quick Ratio	1.86	1.78	-4.16
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.43	12.78	2.78
Cash	4.44	4.93	11.04
Capex	-0.06	-0.06	0.55
Free Cash Flow	0.53	0.09	-83.62
Revenue	1.93	2.76	43.08
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.49	2.38	-4.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.53	-4.50	52.74
Naive Interpretation	Member

06 - Financial Health · Bad

Rating